Skip to content
Aerami Therapeutics

Aerami Therapeutics

Reimagining the treatment of chronic diseases with Inhaled Therapies

  • ABOUT US
  • Inhalation Technology
  • Aerosol Formulations
    • CLINICAL STUDIES
  • INVESTORS + MEDIA
  • CONTACT
  • linkedin
  • twitter

BRIEF-Tonghua Dongbao Pharmaceutical signs new agreement on establishment of biomedicine JV

October 24, 2017
Continue Reading

Categories

  • In The News
  • PRESS RELEASES

Archives

  • 2020
  • 2019
  • 2017

Investor Contact:

Jeremy Feffer
LifeSci Advisors, LLC
(212) 915-2568
jeremy@lifesciadvisors.com

Media Contact:

Gloria Gasaatura
LifeSci Communications
(646) 970-4688
ggasaatura@lifescicomms.com

  • linkedin
  • twitter

2520 Meridian Parkway, Suite 400
Durham, North Carolina 27713
info@aerami.com

© 2020 Aerami Therapeutics.
All Rights Reserved.  Privacy Policy